Literature DB >> 33428061

The role of high mobility group protein B3 (HMGB3) in tumor proliferation and drug resistance.

Bin Wen1, Ying-Ting Wei1, Kui Zhao2.   

Abstract

The high mobility group protein B (HMGB) family (including HMGB1, HMGB2, HMGB3, and HMGB4) can regulate the mechanisms of DNA replication, transcription, recombination, and repair, and act as cytokines to mediate responses to infection, injury, and inflammation. HMGB1/2/3 has a high similarity in sequence and structure, while HMGB4 has no acidic C-terminal tail. Among them, HMGB3 can regulate the self-renewal and differentiation of normal hematopoietic stem cell population, but the decrease of its expression is easy to induce leukemia. Up-regulation of its expression promotes tumor development and chemotherapy resistance through a variety of mechanisms, and non-coding RNA can regulate to promote tumor cell proliferation, invasion, and migration and inhibit cancer cell apoptosis.

Entities:  

Keywords:  DNA; High mobility group-box 3; Hypoxia-inducible factor-1α; Tumor; microRNA

Mesh:

Substances:

Year:  2021        PMID: 33428061     DOI: 10.1007/s11010-020-04015-y

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  89 in total

1.  Suppression of immune responses by nonimmunogenic oligodeoxynucleotides with high affinity for high-mobility group box proteins (HMGBs).

Authors:  Hideyuki Yanai; Shiho Chiba; Tatsuma Ban; Yukana Nakaima; Takashi Onoe; Kenya Honda; Hideki Ohdan; Tadatsugu Taniguchi
Journal:  Proc Natl Acad Sci U S A       Date:  2011-06-27       Impact factor: 11.205

2.  Expression of HMGB2 indicates worse survival of patients and is required for the maintenance of Warburg effect in pancreatic cancer.

Authors:  Xin Cai; Hongjian Ding; Yanxia Liu; Gaofeng Pan; Qingguo Li; Zhen Yang; Weiyan Liu
Journal:  Acta Biochim Biophys Sin (Shanghai)       Date:  2017-02-06       Impact factor: 3.848

3.  Cancer statistics, 2020.

Authors:  Rebecca L Siegel; Kimberly D Miller; Ahmedin Jemal
Journal:  CA Cancer J Clin       Date:  2020-01-08       Impact factor: 508.702

4.  Down-regulated expressed protein HMGB3 inhibits proliferation and migration, promotes apoptosis in the placentas of fetal growth restriction.

Authors:  Yan Lv; Mingming Lv; Xiaohong Ji; Lu Xue; Can Rui; Lingfeng Yin; Hongjuan Ding; Zhijing Miao
Journal:  Int J Biochem Cell Biol       Date:  2018-12-10       Impact factor: 5.085

5.  The effect of the acidic tail on the DNA-binding properties of the HMG1,2 class of proteins: insights from tail switching and tail removal.

Authors:  K B Lee; J O Thomas
Journal:  J Mol Biol       Date:  2000-11-24       Impact factor: 5.469

6.  Targeting the High-Mobility Group Box 3 Protein Sensitizes Chemoresistant Ovarian Cancer Cells to Cisplatin.

Authors:  Anirban Mukherjee; Van Huynh; Kailee Gaines; Wade Alan Reh; Karen M Vasquez
Journal:  Cancer Res       Date:  2019-05-06       Impact factor: 12.701

Review 7.  Targeting Chromosomal Architectural HMGB Proteins Could Be the Next Frontier in Cancer Therapy.

Authors:  Anirban Mukherjee; Karen M Vasquez
Journal:  Cancer Res       Date:  2020-03-09       Impact factor: 12.701

Review 8.  Nuclear functions of the HMG proteins.

Authors:  Raymond Reeves
Journal:  Biochim Biophys Acta       Date:  2009-09-11

9.  Bioinformatics analysis of the prognosis and biological significance of HMGB1, HMGB2, and HMGB3 in gastric cancer.

Authors:  Jian Fang; Xuhui Ge; Wenjing Xu; Jingjing Xie; Zhongke Qin; Liqing Shi; Wenjie Yin; Maohong Bian; Hao Wang
Journal:  J Cell Physiol       Date:  2019-10-16       Impact factor: 6.384

10.  Two high-mobility group box domains act together to underwind and kink DNA.

Authors:  R Sánchez-Giraldo; F J Acosta-Reyes; C S Malarkey; N Saperas; M E A Churchill; J L Campos
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2015-06-30
View more
  5 in total

Review 1.  High Mobility Group Proteins in Sepsis.

Authors:  Guibin Liang; Zhihui He
Journal:  Front Immunol       Date:  2022-06-02       Impact factor: 8.786

2.  Development of a Novel Immune-Related Gene Prognostic Index for Breast Cancer.

Authors:  Yan Yao; Xinru Kong; Ruijuan Liu; Fei Xu; Gongxi Liu; Changgang Sun
Journal:  Front Immunol       Date:  2022-04-26       Impact factor: 8.786

3.  Glaucocalyxin A Inhibits the Malignant Progression of Epithelial Ovarian Cancer by Affecting the MicroRNA-374b-5p/HMGB3/Wnt-β-Catenin Pathway Axis.

Authors:  Feng Chen; Fang Sun; Xia Liu; Jing Shao; Bei Zhang
Journal:  Front Oncol       Date:  2022-07-14       Impact factor: 5.738

4.  Systematic analysis of expression profiles of HMGB family members for prognostic application in non-small cell lung cancer.

Authors:  Xuefeng Zheng; Xu Wang; Yunduan He; Hong Ge
Journal:  Front Mol Biosci       Date:  2022-07-18

5.  HMGB3 promotes PARP inhibitor resistance through interacting with PARP1 in ovarian cancer.

Authors:  Hanlin Ma; Gonghua Qi; Fang Han; Wei Lu; Jiali Peng; Rongrong Li; Shi Yan; Cunzhong Yuan; Beihua Kong
Journal:  Cell Death Dis       Date:  2022-03-24       Impact factor: 8.469

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.